These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 8502996)
21. Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread. Toohey K; Wehrly K; Nishio J; Perryman S; Chesebro B Virology; 1995 Oct; 213(1):70-9. PubMed ID: 7483281 [TBL] [Abstract][Full Text] [Related]
22. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. Connor RI; Ho DD J Virol; 1994 Jul; 68(7):4400-8. PubMed ID: 7515972 [TBL] [Abstract][Full Text] [Related]
23. Relationship of HIV-1 envelope V2 and V3 sequences of the primary isolates to the viral phenotype. Yoshimura K; Matsushita S; Hayashi A; Takatsuki K Microbiol Immunol; 1996; 40(4):277-87. PubMed ID: 8709863 [TBL] [Abstract][Full Text] [Related]
24. Sequence diversity of V1 and V2 domains of gp120 from human immunodeficiency virus type 1: lack of correlation with viral phenotype. Wang N; Zhu T; Ho DD J Virol; 1995 Apr; 69(4):2708-15. PubMed ID: 7884929 [TBL] [Abstract][Full Text] [Related]
25. Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1. van Rij RP; Blaak H; Visser JA; Brouwer M; Rientsma R; Broersen S; de Roda Husman AM; Schuitemaker H J Clin Invest; 2000 Oct; 106(8):1039-52. PubMed ID: 11032864 [TBL] [Abstract][Full Text] [Related]
26. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Zhu T; Mo H; Wang N; Nam DS; Cao Y; Koup RA; Ho DD Science; 1993 Aug; 261(5125):1179-81. PubMed ID: 8356453 [TBL] [Abstract][Full Text] [Related]
27. Envelope diversity, coreceptor usage and syncytium-inducing phenotype of HIV-1 variants in saliva and blood during primary infection. Freel SA; Fiscus SA; Pilcher CD; Menezes P; Giner J; Patrick E; Lennox JL; Hicks CB; Eron JJ; Shugars DC AIDS; 2003 Sep; 17(14):2025-33. PubMed ID: 14502005 [TBL] [Abstract][Full Text] [Related]
28. [Molecular analysis of the principal neutralization epitope (V3 loop) of human immunodeficiency virus type 1 in Argentina]. Gómez Carrillo M; Piccardo C; Libonatti O Rev Argent Microbiol; 1992; 24(2):91-101. PubMed ID: 1298019 [TBL] [Abstract][Full Text] [Related]
29. Sequence analysis of the V1/V2 and V3 domains in an HIV-seronegative AIDS patient. Vallejo A; Bravo R; Heredia A; Soriano V; Dronda F; Hewlett IK AIDS Res Hum Retroviruses; 1995 Dec; 11(12):1539-41. PubMed ID: 8679300 [No Abstract] [Full Text] [Related]
30. Role of low CD4 levels in the influence of human immunodeficiency virus type 1 envelope V1 and V2 regions on entry and spread in macrophages. Walter BL; Wehrly K; Swanstrom R; Platt E; Kabat D; Chesebro B J Virol; 2005 Apr; 79(8):4828-37. PubMed ID: 15795268 [TBL] [Abstract][Full Text] [Related]
31. V3 sequences of paired HIV-1 isolates from blood and cerebrospinal fluid cluster according to host and show variation related to the clinical stage of disease. Keys B; Karis J; Fadeel B; Valentin A; Norkrans G; Hagberg L; Chiodi F Virology; 1993 Oct; 196(2):475-83. PubMed ID: 8372430 [TBL] [Abstract][Full Text] [Related]
32. Isolation and biological characterization of HIV-1 BG intersubtype recombinants and other genetic forms circulating in Galicia, Spain. Pérez-Alvarez L; Muñoz M; Delgado E; Miralles C; Ocampo A; García V; Thomson M; Contreras G; Nájera R; J Med Virol; 2006 Dec; 78(12):1520-8. PubMed ID: 17063519 [TBL] [Abstract][Full Text] [Related]
33. Determinants of syncytium formation in microglia by human immunodeficiency virus type 1: role of the V1/V2 domains. Shieh JT; Martín J; Baltuch G; Malim MH; González-Scarano F J Virol; 2000 Jan; 74(2):693-701. PubMed ID: 10623731 [TBL] [Abstract][Full Text] [Related]
34. The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course? Jurriaans S; Van Gemen B; Weverling GJ; Van Strijp D; Nara P; Coutinho R; Koot M; Schuitemaker H; Goudsmit J Virology; 1994 Oct; 204(1):223-33. PubMed ID: 7916514 [TBL] [Abstract][Full Text] [Related]
35. Increasing antigenic and genetic diversity of the V3 variable domain of the human immunodeficiency virus envelope protein in the course of the AIDS epidemic. Kuiken CL; Zwart G; Baan E; Coutinho RA; van den Hoek JA; Goudsmit J Proc Natl Acad Sci U S A; 1993 Oct; 90(19):9061-5. PubMed ID: 8415653 [TBL] [Abstract][Full Text] [Related]
36. Complex determinants in human immunodeficiency virus type 1 envelope gp120 mediate CXCR4-dependent infection of macrophages. Ghaffari G; Tuttle DL; Briggs D; Burkhardt BR; Bhatt D; Andiman WA; Sleasman JW; Goodenow MM J Virol; 2005 Nov; 79(21):13250-61. PubMed ID: 16227248 [TBL] [Abstract][Full Text] [Related]
37. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. Fouchier RA; Groenink M; Kootstra NA; Tersmette M; Huisman HG; Miedema F; Schuitemaker H J Virol; 1992 May; 66(5):3183-7. PubMed ID: 1560543 [TBL] [Abstract][Full Text] [Related]
38. A model for alignment of Env V1 and V2 hypervariable domains from human and simian immunodeficiency viruses. Lamers SL; Sleasman JW; Goodenow MM AIDS Res Hum Retroviruses; 1996 Aug; 12(12):1169-78. PubMed ID: 8844021 [TBL] [Abstract][Full Text] [Related]
39. The V1/V2 region of human immunodeficiency virus type 1 modulates the sensitivity to neutralization by soluble CD4 and cellular tropism. Morikita T; Maeda Y; Fujii S; Matsushita S; Obaru K; Takatsuki K AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1291-9. PubMed ID: 9339846 [TBL] [Abstract][Full Text] [Related]
40. Blood monocytes infected in vivo by HIV-1 variants with a syncytium-inducing phenotype. Innocenti-Francillard P; Brengel K; Guillon C; Mallet F; Morand P; Gruters R; Seigneurin JM AIDS Res Hum Retroviruses; 1994 Jun; 10(6):683-90. PubMed ID: 8074932 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]